Rona Y. Sonabend, MD
Chief, Diabetes and Endocrinology
Associate Quality Officer for Department of Pediatrics
Associate Professor of Pediatrics, Pediatric Endocrinology & Metabolism, Baylor College of Medicine
Languages: English
Get to know Rona Y. Sonabend, MD
Personal Statement
Dr. Rona Sonabend's philosophy towards healthcare is combining the science of medicine with the art of care delivery in a patient-centered quality driven manner.
Dr. Sonabend’s clinical interests include caring for children with neuro-endocrine dysfunctions with a specialized interest in endocrine complications secondary to treatment of childhood cancer.
When she’s not seeing patients, Rona Sonabend serves as the Medical Director of Clinical Systems Integration Process Improvement, which coordinates and prioritizes Quality Improvement and Safety initiatives focused on data, data analysis, clinical technology operations, information systems platforms and clinical standards at Texas Children’s Hospital. Her role includes supervision of nine complex disease-based care process teams throughout the institution while co-leading the Diabetes Care Process Team. She is also the Medical Director of Quality Improvement for the section of Pediatric Endocrinology.
Education
,
,
Organizations
,
* Texas Children’s Hospital physicians’ licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician’s office and were not verified by Texas Children’s Hospital.
Hollander E, Novotny S, Hanratty M, Yoffe R, DeCaria CM, Aronowitz BR, and Mosovich S. Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger’s disorders. Neuropharmacology 2003 Jan; 28(1):193-8.
Yoffe R, Khakoo Y, Dunkel IJ, Souweidane M, Lis E, and Sklar. C. Recurrent ependymoma treated with high-dose tamoxifen in a peripubertal female: Impact on tumor and the pituitary-ovarian axis. Pediatric Blood & Cancer Oct 15 49 (5) 758-760, 2007.
Sonabend, R.Y., et al. Hyperglycemia during induction therapy is associated with increased infectious complications in childhood acute lymphocytic leukemia. Pediatric Blood & Cancer 2008 51(3): p. 387-92.
Sonabend, R.Y., et al. Hyperglycemia during induction therapy is associated with poorer survival in children with acute lymphocytic leukemia. Journal of Pediatrics2009 July 155(1):73-8.
Menne EN, Sonabend R.Y. , Mason EO, Lamberth LB, Hammerman WA, Minard CG, Kaplan SL, Hulten KG. Staphylococcus aureus infections in pediatric patients with diabetes mellitus. Journal of Infection Aug 2012. 65(2):p. 135-41.